TNFSF11 and Alzheimer disease: Trabecular bone osteoid thickness, adjusted apposition rate, and mineralization lag time from study 2—male adenine-induced CKD mice (AD) treated with risedronate (AD+Ris) or anti-RANKL (AD+Anti-R).